DEVELOPMENT OF A RECEPTOR PEPTIDE ANTAGONIST TO HUMAN GAMMA-INTERFERON AND CHARACTERIZATION OF ITS LIGAND-BOUND CONFORMATION USING TRANSFERRED NUCLEAR OVERHAUSER EFFECT SPECTROSCOPY
Gf. Seelig et al., DEVELOPMENT OF A RECEPTOR PEPTIDE ANTAGONIST TO HUMAN GAMMA-INTERFERON AND CHARACTERIZATION OF ITS LIGAND-BOUND CONFORMATION USING TRANSFERRED NUCLEAR OVERHAUSER EFFECT SPECTROSCOPY, The Journal of biological chemistry, 270(16), 1995, pp. 9241-9249
Polyclonal anti-idiotypic antibody raised to a synthetic discontinuous
peptide derived from the human gamma-interferon (huIFN-gamma) sequenc
e recognizes soluble human gamma-interferon receptor (Seelig, G. F., P
rosise, W. W., and Taremi, S, S, (1994) J. Biol, Chem, 269, 358-363),
We sought to use this reagent to identify a ligand-binding domain with
in IFN-gamma-receptor. To do this, the neutralizing anti-idiotypic ant
ibody was used to probe overlapping linear peptide octamers of the ext
racellular do main of the huIFN-gamma receptor, A 22-amino acid residu
e receptor segment 120-141 identified by the antibody was synthesized,
CD and NMR analysis indicates that peptide 120-141 has no apparent se
condary structure in water or in water containing 50% trifluoroethanol
, The synthetic receptor peptide inhibited huIFN-gamma induced express
ion of HLA/DR antigen on Cole 205 cells with an approximate IC50 of 35
mu M. Immobilized peptide specifically bound recombinant huIFN-gamma
but did not bind human granulocyte-macrophage colony-stimulating facto
r on a microtiter plate in a direct binding enzyme-linked immunosorben
t assay. The binding results are supported by two-dimensional transfer
red nuclear Overhauser effect (TRNOE) NMR data obtained on the peptide
in the presence of recombinant huIFN-gamma. Characterization of the c
onformation of the bound peptide by TRNOE suggests that this peptide a
ssumes a distinct conformation. Intramolecular interactions within the
bound peptide were detected at two non-contiguous regions and at a th
ird region comprising a p-turn formed by the sequence DIRK. We believe
that this represents the structure of the receptor within the ligand-
binding domain.